MLS-573151|CAS 10179-57-4|DC Chemicals

Cas No.:	10179-57-4
Chemical Name:	MLS-573151
Synonyms:	4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide;1-<4-Pyrrolidinomethyl-phenyl>-2-phenyl-6-methoxy-3,4-dihydronaphthalin-hydrochlorid;1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenyl]ethyl]pyrrolidine hydrochloride;4-(2-Pyrrolidino-aethyl)-phenyl>1-(p-(6-Methoxy-2-phenyl-3,4-dihydro-1-naphthyl)phenethyl)pyrrolidine hydrochloride;4-(3,5-diphenyl-4,5-dihydro-pyrazol-1-yl)-benzenesulfonamide;LS-137987;AC1L487J;1-(4-Pyrrolidinomethyl-phenyl)-2-phenyl-6-methoxy-3,4-dihydronaphthalin-hydrochlorid;Pyrrolidine, 1-(p-(6-methoxy-2-phenyl-3,4-dihydro-1-naphthyl)phenethyl)-, hydrochloride;MLS-573151;1-< 4-(2-Pyrrolidino-aethyl)-phenyl> -2-phenyl-6-methoxy-3,4-dihydronaphthalin-hydrochlorid;1-< 4-Pyrrolidinomethyl-phenyl> -2-phenyl-6-methoxy-3,4-dihydronaphthalin-hydrochlorid;LS-13;BS-45816;EN300-1266070;MLS000573151;10179-57-4;HY-113849;UNM-0000305821;CS-0062951;SR-01000393180;4-(3,5-diphenyl-3,4-dihydropyrazol-2-yl)benzenesulfonamide;4-(3,5-diphenyl-2-pyrazolin-1-yl)benzenesulfonamide;VU0010584-3;Z234875142;AKOS001376364;CHEMBL1565276;SR-01000393180-1;SCHEMBL14484122;DA-55563;STK386787;KUC103427N;E75058;HMS2549D16;cid_2837695;4-(3,5-diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzene-1-sulfonamide;ChemDiv1_000199;CCG-15205;NCGC00388162-02;SMR000185086;HMS587J01;UNM-0000306146;BDBM54651;4-(3,5-DIPHENYL-4,5-DIHYDROPYRAZOL-1-YL)BENZENESULFONAMIDE;CBDivE_010550;AKOS016899389;4-(3,5-diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide
SMILES:	C1=CC=C(C=C1)C2=NN(C3=CC=C(C=C3)S(=O)(=O)N)C(C2)C4=CC=CC=C4
Formula:	C₂₁H₁₉N₃O₂S
M.Wt:	377.45946
Purity:	98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.